Viatris (VTRS) EBT (2019 - 2026)
Viatris (VTRS) recorded quarterly EBT of -$247.3 million in Q1 2026, up 27.9% quarter-over-quarter from -$343.0 million in Q4 2025, and up 92.01% on a YoY basis from -$128.8 million in Q1 2025.
Viatris (VTRS) EBT (2019 - 2026) Analysis & Trends
Viatris' EBT history runs 8 years deep, the most recent figure standing at -$247.3 million for Q1 2026.
- In Q1 2026, EBT rose 92.01% year-over-year to -$247.3 million; the TTM figure through Mar 2026 stood at -$815.3 million (up 79.23% YoY), while the FY2025 annual figure was -$3.7 billion, down 488.09% from the prior year.
- EBT was -$247.3 million for Q1 2026 at Viatris, up from -$343.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $1.5 billion in Q4 2022 to a low of -$3.1 billion in Q1 2025.
- Historically, EBT has averaged -$89.4 million across 5 years, with a median of $90.5 million in 2024.
- The sharpest annual moves came in 2022 and 2025: EBT surged 820.4% in 2022, then slumped 1613.69% in 2025.
- A 5-year view of EBT shows it stood at $1.5 billion in 2022, then plunged by 158.21% to -$855.0 million in 2023, then surged by 38.42% to -$526.5 million in 2024, then jumped by 34.85% to -$343.0 million in 2025, then climbed by 27.9% to -$247.3 million in 2026.
- The last three EBT figures came in at -$247.3 million (Q1 2026), -$343.0 million (Q4 2025), and -$7.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 437.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 758.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 318.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 17.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 246.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 87.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -61.93 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 156.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -101.55 Mn |
| 10 | Viatris | - | - | 1.16 Bn | -247.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247.30 Mn |
| Dec 31, 2025 | -343.00 Mn |
| Sep 30, 2025 | -7.90 Mn |
| Jun 30, 2025 | -217.10 Mn |
| Mar 31, 2025 | -3.10 Bn |
| Dec 31, 2024 | -526.50 Mn |
| Sep 30, 2024 | 90.50 Mn |
| Jun 30, 2024 | -391.80 Mn |
| Mar 31, 2024 | 204.60 Mn |
| Dec 31, 2023 | -855.00 Mn |
| Sep 30, 2023 | 402.20 Mn |
| Jun 30, 2023 | 333.00 Mn |
| Mar 31, 2023 | 322.70 Mn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 427.50 Mn |
| Jun 30, 2022 | 389.30 Mn |
| Mar 31, 2022 | 527.50 Mn |
| Dec 31, 2021 | -203.90 Mn |
| Sep 30, 2021 | 199.90 Mn |
| Jun 30, 2021 | -219.10 Mn |